References
- Hair PI, Scott LJ. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006;66:973–96
- Devalia JL, De Vos C, Hanotte F, et al. A randomised, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 2001;56:50–7
- Gillard M, Van Der Perren C, Moguilevsky N, et al. Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: contribution of Lys191 and Thr194. Mol Pharmacol 2002;61:391–9
- Thomson L, Blaylock MG, Sexton DW, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 2002;32:1187–92
- De Vos C, Mitchev K, Pinelli ME, et al. Non-interventional study comparing treatment satisfaction in patients treated with antihistamines. Clin Drug Invest 2008;28:221–30
- Simons FER. Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr Allergy Immunol 2007;18:535–42
- Ferrer M, Morais-Almeida M, Guizova M, et al. Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non-interventional, retrospective study. Clin Drug Investig 2010;30:15–34
- Ino H, Nohda S, Miki S, et al. Comparisons of the pharmacokinetics of levocetirizine after single doses of levocetirizine hydrochloride and cetirizine hydrochloride in healthy Japanese male subjects. Jpn J Clin Pharmacol Ther 2010;41:309–15
- Strolin BM, Plisnier M, Kaise J, et al. Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers. Eur J Clin Pharmacol 2001;57:571–82
- Kito Y, Kito Y, Tokura Y. Clinical effectiveness of zyrtec dyrup (1.25% cetirizine hydrochloride) in pediatric atopic dermatitis and questionnaire survey of iompliances to patients and parents. Prog Med 2013;33:1211–4
- Shimojo N, Kono Y. Actual conditions of treatment with second generation antihistamine drugs in infants. Prog Med 2009;29:207–17
- Kang SW, Jang HJ, Moore VS, et al. Enantioselective determination of cetirizine in human plasma by normal-phase liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. J Chromatogr B 2010;878:3351–7
- Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour, and Welfare. Guideline for bioequivalence studies of generic products. Notification 0229 No.10. 2012. Available at: http://www.nihs.go.jp/drug/be-guide(e)/Generic/GL-E_120229_BE.pdf
- Baltes E, Coupez R, Giezek H, et al. Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundam Clin Pharmacol 2001;15:269–77
- Pampura AN, Papadopoulos NG, Spicak V, et al. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease. Int Arch Allergy Immunol 2011;155:367–78
- Devillier P, Roche N, Faisy C. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine: a comparative review. Clin Pharmacokinet 2008;47:217–30